Get the Weekly Intelligence Brief — top committee picks every Sunday.
BEKE · NYSE · STOCK

KE Holdings (BEKE) Stock Analysis

Real Estate Updated October 14, 2026
$17.73
52W $13.81 – $19.88
63/100
$19.43B
27.2
-0.33
AI Committee Verdict
Buy
63/100
Conviction: Contested · 50% agreement · 6 analysts
+7.8%
-0.4%
18.05:1
Contested

Is BEKE Bullish or Bearish?

Bullish. Innellis AI committee rates KE Holdings Inc. (BEKE) Buy with a composite score of 63/100 , based on 6 analysts with 50% agreement. Last updated October 14, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +11.63 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -8.37 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.75 across 8 articles, 14d). Portfolio Manager remains cautious — 2 existing position pair(s) are highly correlated already. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • EPS growing 25.9% YoY — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • Low leverage (debt-to-equity 0.02) -- balance sheet can absorb a shock — Risk
  • News sentiment is positive (+0.75 across 8 articles, 14d) — News
Bear Case
  • P/E of 28.7 is moderate-to-rich — Value
  • Revenue declining -13.9% YoY -- this is not a growth story right now — Growth
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 14, 2026
Overall Committee Score
63/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 3%
of 80 Real Estate peers
Value Analyst neutral
55 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− P/E of 28.7 is moderate-to-rich
Growth Analyst neutral
45 / 100 · High confidence
Moderate growth -- present but not remarkable
+ EPS growing 25.9% YoY
− Revenue declining -13.9% YoY -- this is not a growth story right now
Technical Analyst neutral
58 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst bullish
75 / 100 · Moderate confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.02) -- balance sheet can absorb a shock
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
82 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.75 across 8 articles, 14d)
Portfolio Manager bearish
35 / 100 · Low confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− 2 existing position pair(s) are highly correlated already
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 65.7 to 63.4.

Analyst-level changes:
  • Macro Analyst: score 80->65 (-15).
  • News Analyst: +1 bullish signal(s).
  • Portfolio Manager: score 30->35 (+5).
  • Value Analyst: +1 bearish signal(s).

Comparing 2026-10-13 to 2026-10-14 (1 day apart).

Technical Analysis

RSI (14)
63.8
Neutral
MACD Histogram
0.136
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Hh Hl
Support
$17.45
Resistance
$18.89
Bollinger %B
0.86
Inside Bands
Price vs Moving Averages
EMA 9
$17.27 Above
EMA 21
$17.04 Above
EMA 50
$16.92 Above
EMA 200
$16.96 Above

Fundamental Analysis

Valuation
80
Growth
55
Profitability
21
Financial Health
88
Cash Flow
70
Valuation
P/E Ratio 27.2×
P/B Ratio 1.93×
PEG Ratio 1.08
Dividend Yield 1.57%
52W High $19.88
52W Low $13.81
Quality & Growth
ROE 450.6%
ROA 256.6%
Gross Margin 2405.0%
Operating Margin 621.3%
Revenue Growth YoY —
Debt / Equity 0.22
AI Fundamental Assessment
P/E ratio of 27.2 (moderate relative to a 15-40x range); Price-to-book of 1.9x; PEG ratio of 1.1 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 4.5%; Return on assets of 2.6%; Net margin of 5.4%; Gross margin of 24.1%; Current ratio of 1.70 (healthy short-term liquidity); Debt-to-equity of 0.22; Free cash flow per share is positive (0.63); Most recent quarter beat estimates by 24.0%; EPS growth decelerating (+213.3% -> +102.1% QoQ); Average YoY EPS growth of 83.4%; Analyst estimates rising over recent quarters
Get the Full BEKE Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime